Efficacy and Safety In Poorly Controlled Type 2 Diabetics
NCT00044460
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
rosiglitazone
Sponsor
GlaxoSmithKline